Ultrastructure of a Carbon Nanotube-based Delivery System for Cancer Therapy
用于癌症治疗的碳纳米管输送系统的超微结构
基本信息
- 批准号:8340620
- 负责人:
- 金额:$ 2.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdsorptionAntineoplastic AgentsAreaBindingBiological AssayCarbon NanotubesCell NucleusCell ProliferationCell SurvivalCell membraneCellsChemicalsCisplatinConfocal MicroscopyCytoplasmDataDehydrationDevelopmentDrug Delivery SystemsElectron MicroscopyElectronsEpidermal Growth FactorEpidermal Growth Factor ReceptorEpithelialFluorescence MicroscopyFutureGlutaralHead and Neck Squamous Cell CarcinomaImageImageryIn VitroIncubatedIndividualLengthLifeLigandsMalignant Epithelial CellMalignant NeoplasmsMeasurementMusNanotubesNational Institute of Dental and Craniofacial ResearchOpticsOsmium TetroxidePharmaceutical PreparationsPlatinumRelative (related person)ResolutionScanning Transmission Electron Microscopy ProceduresSpectroscopy, Fourier Transform InfraredSquamous cell carcinomaSubcellular structureSurfaceSystemTherapeuticTimeTransmission Electron Microscopybasecancer cellcancer therapydesigneponinfrared spectroscopyintravital fluorescence microscopykillingsluminescencemalignant mouth neoplasmnanoparticleoverexpressionreceptor bindingresearch studysample fixationsingle moleculesingle walled carbon nanotubetomographytumortumor growth
项目摘要
Carbon nanotubes with attached drugs and directing ligands have excellent potential for targeted drug delivery. Single wall carbon nanotubes (SWNT) with very highly specific surface areas can be derivatized with biomolecules either through chemical attachment, adsorption or encapsulation. Such bioconjugates on SWNTs have the ability to deliver bioactive molecules across cell membranes and even into cell nuclei. We have performed ultrastructural experiments to characterize the nanobioconjugates and to investigate the application of functionalized carbon nanotubes to deliver therapeutic drugs to oral cancer cells. The anti-cancer drug cisplatin was covalently bound to single walled carbon nanotubes (SWNTs) and these were in turn bound to epidermal growth factor (EGF), which is expressed at very high levels by oral cancer cells. Characterization of such SWNT nanobioconjugates is important for the successful development of these functional bionanomaterials. We have applied atomic-scale scanning transmission electron microscopy (STEM) to visualize and quantitate single Pt-based drug molecules attached to single-wall carbon nanotubes designed for targeted drug-delivery. Annular dark-field STEM imaging enabled visualization of the first-line anticancer drug cisplatin on the nanotubes at single molecule levels. The identity and presence of cisplatin on the nanotubes were confirmed using energy-dispersive x-ray spectroscopy and Fourier transform infrared spectroscopy. STEM tomography was also used to provide additional information about the loading of cisplatin on the nanotube bioconjugates.
Cultured head and neck squamous cell carcinoma (HNSCC) cells of epithelial origin incubated with the functionalized nanoparticles were prepared for electron microscopy by fixation in glutaraldehyde and osmium tetroxide, followed by dehydration and embedding in epon. Electron micrographs, recorded digitally using a 120 kV TEM, revealed that bundles of SWNTs had entered the cells. In most HNSCC cells the SWNT bundles were distributed throughout the cytoplasm, whereas some cells showed a higher concentration of nanotubes adjacent to the cell nucleus. The results confirmed lower resolution data obtained from confocal fluorescence microscopy but provided more detailed information about the subcellular structures associated with the nanotubes after entry. The ultrastructural data are being correlated with optical measurements and cell viability assays conducted in NIDCR. We have also used scanning transmission electron microscopy (STEM) and x-ray nanoanalysis to characterize individual nanotubes and to determine the distribution of bound platinum atoms. Characterization of these nanoparticle bioconjugates is essential for the future progress of this approach. In particular, nanotube size, and number of biomolecules per nanotube length are important parameters, especially for drug delivery. Our STEM results show for the first time atomic scale visualization and quantification of single Pt-based drug molecules attached to SWNTs.
碳纳米管与药物和定向配体的连接具有良好的靶向给药潜力。单壁碳纳米管(SWNT)具有非常高的比表面积,可以通过化学附着、吸附或包封与生物分子衍生。单壁碳纳米管上的这种生物缀合物具有将生物活性分子递送穿过细胞膜甚至进入细胞核的能力。我们进行了超微结构实验来表征纳米生物缀合物,并研究功能化碳纳米管在向口腔癌细胞递送治疗药物方面的应用。抗癌药物顺铂与单壁碳纳米管(SWNT)共价结合,这些碳纳米管又与表皮生长因子(EGF)结合,后者在口腔癌细胞中以非常高的水平表达。 这种单壁碳纳米管纳米生物复合物的表征对于这些功能性生物纳米材料的成功开发是重要的。我们已经应用了原子级扫描透射电子显微镜(STEM)可视化和定量的单Pt为基础的药物分子连接到单壁碳纳米管设计的靶向药物输送。 环形暗场STEM成像使一线抗癌药物顺铂在单分子水平上在纳米管上可视化。 使用能量色散X射线光谱和傅里叶变换红外光谱的身份和存在的顺铂的纳米管进行了确认。 STEM断层扫描也用于提供关于顺铂在纳米管生物缀合物上的负载的额外信息。
通过在戊二醛和四氧化锇中固定,然后脱水并包埋在epon中,制备与功能化纳米颗粒孵育的上皮来源的培养的头颈部鳞状细胞癌(HNSCC)细胞用于电子显微镜检查。使用120 kV TEM数字记录的电子显微照片显示,成束的SWNT已经进入细胞。在大多数HNSCC细胞中,SWNT束分布在整个细胞质中,而一些细胞显示出较高浓度的纳米管邻近细胞核。结果证实了从共聚焦荧光显微镜获得的较低分辨率的数据,但提供了更详细的信息与纳米管进入后的亚细胞结构。超微结构的数据正在与光学测量和细胞活力测定进行NIDCR。我们还使用扫描透射电子显微镜(STEM)和X射线纳米分析来表征单个纳米管,并确定结合铂原子的分布。这些纳米颗粒生物共轭物的表征是这种方法的未来进展所必需的。特别地,纳米管尺寸和每纳米管长度的生物分子数量是重要的参数,尤其是对于药物递送。我们的STEM结果首次显示了附着在单壁碳纳米管上的单个铂基药物分子的原子尺度可视化和定量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Leapman其他文献
Richard Leapman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Leapman', 18)}}的其他基金
Platinum Accumulation in Pigmented Granules of Cisplatin-Treated Melanoma Cells
顺铂处理的黑色素瘤细胞色素颗粒中铂的积累
- 批准号:
7967892 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
Development of Conjugated Gold Clusters for Studies on Cellular Internalization
用于细胞内化研究的共轭金簇的开发
- 批准号:
8933888 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
Electron microscopy of therapeutic and diagnostic nanoparticles
治疗和诊断纳米颗粒的电子显微镜
- 批准号:
9152063 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
Intramural Training of NIH Biomedical Imaging and Bioengineering Researchers
NIH 生物医学成像和生物工程研究人员的校内培训
- 批准号:
8340644 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM
通过串行块面 SEM 进行三维细胞和组织重建
- 批准号:
9361491 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
Energy-Filtered Electron Microscopy and Electron Spectroscopic Imaging
能量过滤电子显微镜和电子光谱成像
- 批准号:
10011332 - 财政年份:
- 资助金额:
$ 2.55万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 2.55万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 2.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 2.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 2.55万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 2.55万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 2.55万 - 项目类别:














{{item.name}}会员




